- Published at
- by benzinga.com
negative
negative
aTyr Pharma Gains On New Programs From tRNA Synthetase Platform For Cancer Targets
aTyr Pharma Inc (NASDAQ: LIFE) has initiated two discovery programs from its tRNA synthetase platform that will investigate the ...